The European consortium BRAVƎ, made by 14 organisations, held its annual virtual meeting to assess the difficulties and successes of this first-year coinciding with the global pandemic on November 19th and 20th 2020. 

The consortium is advancing in the different activities of the project to reach the following milestones in the next year: from a new bioreactor to some large scale bioengineered heart tissues.

PNO, leader of exploitation activities within the project, recently completed the mapping of the relevant stakeholders for BRAV∃ innovations in the targeted markets and research domains.

Are you interested in the project? Get in touch with us!